GlassScriptPhysician profile
Nicole Hinderleider
NPI 1164978367
$1,055.56
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $483 · 2022: $341 · 2023: $51.35 · 2024: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $376.64 | 2021-2024 | Epclusa |
| Glaxosmithkline, LLC. | $188.06 | 2021-2023 | Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $187.50 | 2021-2024 | Fanapt |
| Novo Nordisk INC | $64.17 | 2021-2023 | Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $49.87 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.72 | 2022 | |
| Organon LLC | $42.74 | 2021 | |
| Alkermes, INC. | $24.82 | 2021 | |
| Sobi, INC | $20.40 | 2021 | |
| Daiichi Sankyo INC. | $19.39 | 2021 | |
| Pfizer INC. | $18.95 | 2023 | |
| Sunovion Pharmaceuticals INC. | $18.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Hinderleider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.